Aktieanalys

Inhalation Sciences: Rights issue announcement - Redeye

Redeye Publicerad: 06 Apr 2023 12:16

Redeye comments on ISAB’s rights issue announcement of approximately SEK17.1m before issue-related costs. The subscription price is set to SEK3.6, corresponding to a c31% discount compared to yesterday’s closing price. Moreover, the issue is guaranteed up to 80% by subscription commitments (c10.4%) and guarantee commitments (c69.6%). We had already included an assumed rights issue in our valuation; however, we will not adjust our model before the outcome in May.

Länk till analysen i sin helhet: https://www.redeye.se/research/892808/inhalation-sciences-rights-issue-announcement?utm_source=finwire&utm_medium=RSS

Nyheter om Inhalation Sciences

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!